Abstract
Advances in quantitative mass spectrometry technology have paved the way for routine use in clinical laboratories. One application is steroid analysis for investigation of gonadal and adrenal diseases. In oncology, routine use of steroid analysis is primarily restricted to testosterone analysis for addressing the castration level in androgen deprivation therapy and estradiol measurement to support determination of menopausal status. The increasing analytical performance of liquid chromatography–mass spectrometry (LC–MS)-based quantitative steroid analysis, opens opportunities for investigating new clinical applications. One of these is monitoring hormonal therapy in breast and prostate cancer patients. Several (pre-)analytical issues should be addressed when developing LC–MS-based steroid assays for these purposes. Assays that comprise multiple steroids provide an interesting approach to efficiently investigate a large variety of potential candidates.
Similar content being viewed by others
References
Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, Meyer-Bahlburg HF, Miller WL, Montori VM, Oberfield SE, Ritzen M, White PC (2010) Int J Pediatr Endocrinol 2010:494173
Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, Welt CK, Endocrine S (2013) J Clin Endocrinol Metab 98:4565–4592
Folkerd EJ, Lonning PE, Dowsett M (2014) J Clin Oncol 32:1396–1400
Rove KO, Debruyne FM, Djavan B, Gomella LG, Koul HK, Lucia MS, Petrylak DP, Shore ND, Stone NN, Crawford ED (2012) Urology 80:754–762
Ketha H, Kaur S, Grebe SK, Singh RJ (2014) Curr Opin Endocrinol Diabetes Obes 21:217–226
Greenspan FS, Baxter JD (1994) Basic & clinical endocrinology, 4th edn
Labrie F (2010) Prog Brain Res 182:97–148
Marchetti PM, Barth JH (2013) Ann Clin Biochem 50:95–107
Rižner TL (2013) Mol Cell Endocrinol 381:124–139
Handelsman DJ, Wartofsky L (2013) J Clin Endocrinol Metab 98:3971–3973
Kushnir MM, Rockwood AL, Roberts WL, Yue B, Bergquist J, Meikle AW (2011) Clin Biochem 44:77–88
Middle JG, Kane JW (2009) Ann Clin Biochem 46:441–456. doi:10.1258/acb.2009.009102
Pauwels S, Antonio L, Jans I, Lintermans A, Neven P, Claessens F, Decallonne B, Billen J, Vanderschueren D, Vermeersch P (2013) Anal Bioanal Chem 405:8569–8577
Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H (2007) J Clin Endocrinol Metab 92:405–413
Rosner W, Hankinson SE, Sluss PM, Vesper HW, Wierman ME (2013) J Clin Endocrinol Metab 98:1376–1387
Owen LJ, MacDonald PR, Keevil BG (2013) Ann Clin Biochem 50:368–370
Crawford ED (2009) Urology 73:S4–S10
Saylor PJ (2013) Nat Rev Clin Oncol 10:126–128
de Bono JS, Logothetis CJ, Molina A, Fizazi K, North S, Chu L, Chi KN, Jones RJ, Goodman OB Jr, Saad F, Staffurth JN, Mainwaring P, Harland S, Flaig TW, Hutson TE, Cheng T, Patterson H, Hainsworth JD, Ryan CJ, Sternberg CN, Ellard SL, Fléchon A, Saleh M, Scholz M, Efstathiou E, Zivi A, Bianchini D, Loriot Y, Chieffo N, Kheoh T, Haqq CM, Scher HI, C-A- Investigators (2011) N Engl J Med 364:1995–2005
Labrie F (2014) J Steroid Biochem Mol Biol. [Epub ahead of print]
Droog M, Beelen K, Linn S, Zwart W (2013) Eur J Pharmacol 717:47–57
Chang J, Fan W (2013) Anticancer Agents Med Chem 13:464–475
Weykamp CW, Penders TJ, Schmidt NA, Borburgh AJ, van de Calseyde JF, Wolthers BJ (1989) Clin Chem 35:2281–2284
Kushnir MM, Blamires T, Rockwood AL, Roberts WL, Yue B, Erdogan E, Bunker AM, Meikle AW (2010) Clin Chem 56:1138–1147
Rothman MS, Carlson NE, Xu M, Wang C, Swerdloff R, Lee P, Goh VH, Ridgway EC, Wierman ME (2011) Steroids 76:177–182
Manni A, Pardridge WM, Cefalu W, Nisula BC, Bardin CW, Santner SJ, Santen RJ (1985) J Clin Endocrinol Metab 61:705–710
Hammes A, Andreassen TK, Spoelgen R, Raila J, Hubner N, Schulz H, Metzger J, Schweigert FJ, Luppa PB, Nykjaer A, Willnow TE (2005) Cell 122:751–762
Vermeulen A, Verdonck L, Kaufman JM (1999) J Clin Endocrinol Metab 84:3666–3672
Shi RZ, van Rossum HH, Bowen RA (2012) Clin Biochem 45:1706–1709
Bui HN, Struys EA, Martens F, de Ronde W, Thienpont LM, Kenemans P, Verhoeven MO, Jakobs C, Dijstelbloem HM, Blankenstein MA (2010) Ann Clin Biochem 47:248–252
Star-Weinstock M, Williamson BL, Dey S, Pillai S, Purkayastha S (2012) Anal Chem 84:9310–9317
Ziegler RG, Faupel-Badger JM, Sue LY, Fuhrman BJ, Falk RT, Boyd-Morin J, Henderson MK, Hoover RN, Veenstra TD, Keefer LK, Xu X (2010) J Steroid Biochem Mol Biol 121:538–545
Ray JA, Kushnir MM, Bunker A, Rockwood AL, Meikle AW (2012) Clin Chim Acta 413:1008–1014
Zhao H, Jiang Y, Liu Y, Yun C, Li L (2014) Horm Metab Res. [Epub ahead of print]
Van Rossum HH, Faix JD, Shi RZ (2012) Ned Tijdschr Klin Chem Labgeneesk 37:229–231
Fiers T, Casetta B, Bernaert B, Vandersypt E, Debock M, Kaufman JM (2012) J Chromatogr B Analyt Technol Biomed Life Sci 893–894:57–62
Keski-Rahkonen P, Huhtinen K, Desai R, Harwood DT, Handelsman DJ, Poutanen M, Auriola S (2013) J Mass Spectrom 48:1050–1058
Author information
Authors and Affiliations
Corresponding author
Additional information
Published in the topical collection Recent Developments in Clinical Omics with guest editors Martin Giera and Manfred Wuhrer.
Rights and permissions
About this article
Cite this article
van Rossum, H.H., Bergman, A.M. & Lentjes, E. Analytical Challenges and Potential Applications of Sex Steroid Hormone Analysis in Breast and Prostate Cancer Patients. Chromatographia 78, 359–365 (2015). https://doi.org/10.1007/s10337-014-2797-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10337-014-2797-3